<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08437013001366</udiDi>
    <basicUdiDi>8437013001MCENTELLA6S</basicUdiDi>
    <tradeName>Muvagyn Centella Asiatica</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Casen Recordati, S.L.</manufacturerName>
    <manufacturerSrn>ES-MF-000002442</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>not applicable</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:04:01.949Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437013219310</udiDi>
    <basicUdiDi>8437013219cremavaginalADD</basicUdiDi>
    <tradeName>Seidigyn crema calmante íntima</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Seid</manufacturerName>
    <manufacturerSrn>ES-MF-000004010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>221136.0M</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:04:01.910Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437013219358</udiDi>
    <basicUdiDi>8437013219cremavaginalADD</basicUdiDi>
    <tradeName>SEIDYCALM</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Seid</manufacturerName>
    <manufacturerSrn>ES-MF-000004010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>216445.1M</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:04:01.827Z</lastUpdated>
  </row>
  <row>
    <udiDi>04260605482380</udiDi>
    <basicUdiDi>B-04260605482380</basicUdiDi>
    <tradeName>Curamor Hydro</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Karex Industries Sdn. Bhd.</manufacturerName>
    <manufacturerSrn>MY-MF-000001247</manufacturerSrn>
    <authorisedRepresentativeName>Advena Limited</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>MT-AR-000000234</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MSGL100</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T23:58:15.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>04251778109525</udiDi>
    <basicUdiDi>42517781MD368DF</basicUdiDi>
    <tradeName>Gynaedron</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HÄLSA Pharma GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007407</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FRT00202</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T16:52:59.617Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595872009</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>2014</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:33:22.720Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871705</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA вагинални овули</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2036</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:33:20.539Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871200</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CIKATRIDINA hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1080</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:33:18.348Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870371</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA вагинални овули</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1051</reference>
    <placedOnMarketCountry>Bulgaria</placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:33:16.167Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870210</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA vajinal ovül</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>1017</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:33:13.810Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870166</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina vaginální čípky</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1038</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.901Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870197</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cikatridina hüvelykúp</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1037</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.893Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870272</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina óvulos vaginales</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.846Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870456</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>REPADINA PLUS vagitorier</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1054</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.786Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870463</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina ovules vaginaux</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>1016</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.778Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595870814</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>Cicatridina vagitoriji</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1010</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.595Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871231</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA OVULI VAGINALI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.467Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871248</udiDi>
    <basicUdiDi>803259587TF01EB</basicUdiDi>
    <tradeName>CICATRIDINA OVULI VAGINALI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2001</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.448Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871293</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>FLUVADIN PLUS ovuli vaginali</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.363Z</lastUpdated>
  </row>
  <row>
    <udiDi>08032595871309</udiDi>
    <basicUdiDi>803259587TF03EF</basicUdiDi>
    <tradeName>FLUVADIN PLUS ovuli vaginali</tradeName>
    <deviceName></deviceName>
    <manufacturerName>FARMA-DERMA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000020737</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>U0803</emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>2003</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T05:07:49.349Z</lastUpdated>
  </row>
</eudamedExport>